New hope for lupus skin sufferers: experimental drug enters Mid-Stage trial
Disease control
Recruiting now
This study tests an investigational drug called IMVT-1402 in people with active lupus skin disease (subacute or chronic cutaneous lupus). About 56 adults will receive either the drug or a placebo for 12 weeks, then all will get the drug for 14 more weeks, followed by a longer ext…
Phase: PHASE2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated May 06, 2026 16:13 UTC